| Net Cash Provided by (Used in) Operating Activities |
-594M |
USD |
-73.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
464M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
40.2M |
USD |
-94.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
87M |
shares |
+0.18% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-89.8M |
USD |
+41.9% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
220M |
USD |
+17.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
144M |
USD |
-14.4% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
102M |
USD |
-14.2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
22.4M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
22.4M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
144M |
USD |
-14.4% |
Q4 2024 |
FY 2024 |
| Interest Expense |
713M |
USD |
+12.2% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |